Latest news with #UH-60
Yahoo
22-05-2025
- Business
- Yahoo
Reasons to Include Triumph Group Stock in Your Portfolio Now
Triumph Group, Inc. TGI, with rising earnings estimates, better solvency, strong liquidity, robust backlog and growing aftermarket business, offers a great investment opportunity in the Zacks Aerospace Defense Equipment us focus on the reasons that make this Zacks Rank #1 (Strong Buy) stock an attractive investment pick at the moment. The Zacks Consensus Estimate for Triumph Group's fiscal 2026 earnings per share (EPS) has increased 2.9% to $1.06 per share over the past 60 Zacks Consensus Estimate for fiscal 2026 revenues is pegged at $1.33 billion, which indicates a year-over-year increase of 11.6%.TGI delivered an average earnings surprise of 159.38% in the trailing four quarters. TGI's current ratio at the end of the third quarter of fiscal 2025 was 2.50, higher than the industry's average of 1.79. The ratio being greater than one indicates the company's ability to meet its future short-term liabilities without difficulties. Triumph Group's times interest earned ratio (TIE) at the end of the third quarter of fiscal 2025 was 1.2. The TIE ratio of more than 1 indicates that the company will be able to meet its interest payment obligations in the near term without any problems. TGI has been receiving a constant stream of orders from its diversified customer base. Due to its wide range of superior products, the company keeps receiving orders from manufacturers of commercial aircraft and other military agencies worldwide, expanding its order book. This must have led to a solid backlog of $1.87 billion as of Dec. 31, 2024. Triumph Group announced that its Actuation Products and Services division delivered more than $28 million of aftermarket shipments to support Boeing 787 and Airbus A380 Landing Gear overhaul activity, year to date for fiscal 2025. This was the largest shipping volume Triumph Group had ever military aftermarket sales climbed 31.5% in the last reported quarter, driven by increasing repair volume on the UH-60 platform and spare volume on the CH-47. In the third quarter of fiscal 2025, its commercial aftermarket sales climbed 42.3% year over year due to increasing spares and repair sales volume across multiple platforms, including the Boeing 737 and 787 programs. In the past six months, TGI shares have rallied 35.5% compared with its industry's return of 1.3%. Image Source: Zacks Investment Research A few other top-ranked stocks from the same industry are Curtiss-Wright Corp. CW, Woodward, Inc. WWD and FTAI Aviation Ltd. FTAI, each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today's Zacks #1 Rank stocks long-term earnings growth rate is 12%. The Zacks Consensus Estimate for the company's total revenues for 2025 stands at $3.38 billion, which indicates year-over-year growth of 8.3%.Woodward's long-term earnings growth rate is 13%. The Zacks Consensus Estimate for WWD's fiscal 2025 sales is pegged at $3.45 billion, which implies an improvement of 3.7%.The Zacks Consensus Estimate for FTAI's 2025 EPS stands at $5.14 per share, which calls for a massive year-over-year upsurge of 1,706.3%. The Zacks Consensus Estimate for FTAI's total revenues for 2025 is pegged at $2.11 billion, which suggests growth of 21.8%. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Triumph Group, Inc. (TGI) : Free Stock Analysis Report Curtiss-Wright Corporation (CW) : Free Stock Analysis Report Woodward, Inc. (WWD) : Free Stock Analysis Report FTAI Aviation Ltd. (FTAI) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
16-05-2025
- Business
- Yahoo
New US Army helo engine lifts off, but may be headed for cancellation
NASHVILLE, Tenn. − For the first time, the Army's UH-60M Black Hawk utility helicopter lifted off the ground into a hover at a Sikorsky test facility, powered by the improved turbine engine that has been in development since the mid-2000s, according to the service's program executive officer for aviation. But as the Improved Turbine Engine Program leaps that hurdle toward the finish line, the effort is in jeopardy as the service looks to cut large programs to make way for the pursuit of what it sees as higher priorities amid the need to cut its budget by 8% as directed by the defense secretary. Army Vice Chief of Staff, Gen. James Mingus told reporters at the Army Aviation Association of America confab here that the service is waiting to see where it lands with the fiscal 2026 budget. Officials are trying to gauge how much flexibility the service has in the budget reconciliation process to fully understand if it can afford to pay for ITEP. 'The future of ITEP is largely going to depend on where all these things land inside the '26 budget,' Mingus said. Currently, there is no funding planned to move the program from development into production. Amid mixed messages on the engine's fate over the past several weeks, following the release of an Army directive outlining sweeping change to the service dubbed by the service secretary as the Army Transformation Initiative, Army aviation leaders are working on various potential paths for the engine. Options include outright cancellation, a continuation of the development program followed by its closeout, or a decision to proceed into production. 'We have two weeks, and now there are several programs named, you know, each of them come with a set of courses of action that we have been working on to make sure that we can meet Army senior leaders' intent,' Brig. Gen. David Phillips, the Army's program executive officer for aviation, told reporters May 15 at the Army Aviation Association of America. The ITEP program kicked off in a competition 15 years ago to replace the engines in both the UH-60 and the AH-64 Apache attack helicopter. But the engine effort has been plagued by various delays across its life as the service wrestled with funding, development strategies and a protest from the Advanced Turbine Engine Company – a Honeywell and Pratt & Whitney team, which competed against General Electric's aerospace division to build the engine for the Army. More recently, the engine was hit with more delays due to technical issues as well as the coronavirus pandemic, which caused supply chain problems. When GE won the contract, it touted a plan to move more quickly, but that window to accelerate closed and the Army subsequently predicted a two-year delay getting the T901 engine into the UH-60 Black Hawk, the first aircraft in the current fleet to receive the new tech. The Army was able to garner some important data when it chose to integrate the ITEP onto two competitive prototypes for the Future Attack Reconnaissance Aircraft. The companies in that competition – Bell and Sikorsky – had both received the engines and were installing them when the service decided to cancel the FARA program early last year. When the service canceled the FARA pursuit, it also delayed a production decision for the ITEP engine by three years. Sikorsky had taken advantage of fiscal 2024 FARA program funding before the Army officially closed the program at the end of the year to run tests of the ITEP in the prototype, ahead of integrating the engine into the UH-60, in order to drive down risk. The company received the first ITEP engines for the Black Hawk last fall and began ground runs earlier this year. 'We're currently still under contract to execute the program we were for ITEP,' Rich Benton, Sikorsky's head, told Defense News in an interview at the AAAA event. 'There's still budget in 2025 to continue that work. Will there be budget in the future years or not? You know, that's up to the Army and the [congressional] appropriators,' he said. 'The budget we have today, we'll get the Black Hawk in the air,' he said in a May 14 interview. 'How much flying and how much data we get from that will be up to the Army,' Benton said. 'We're looking at a path ahead in real time on the options and the options could be finish [integration], because there's not just the aircraft integration going on, but there's also the engine qualification testing that is going on in test stands,' Phillips said. 'We've had engines in test stands now for several years gathering low altitude, high altitude, low performance, high performance data. All of that data is very rich and informing the path ahead.' Additionally, the Army continues to have discussions with its joint partners regarding their interest in the engine and how they might integrate it onto their aircraft and a potential path forward there, according to Phillips. And foreign partners have also asked the same question about how they could potentially move forward with the ITEP engine as well. 'We're presenting all those, on how we could get Army senior leaders to meet their intent but get the most out of the dollars that we've invested in the program,' he said. Overall, the Army has spent over an estimated $1.5 billion over the past two decades on ITEP and its precursor development. The service had spent approximately $720 million on the program by 2016. The Army's contracts to competitors in 2016 totaled $256 million and the service awarded a $517 million contract for the engineering and manufacturing development phase to GE in 2019. What is under consideration for a different path to modernize the Black Hawk and Apache's engines, if the Army chooses to end the ITEP program prior to production, is unclear. 'If I had to decide today, hey, if that engine isn't going to be available in the future, what would I do differently? Integrate a different engine? I would quickly pivot to the engine the [Special Operations forces] flies. The SOF flies with a more powerful engine,' Benton said. 'Today it's been integrated in Black Hawk, it has been demonstrated. It is available today, so there would be commonality that would provide some more capability than I have today, [but] not as much as ITEP.' The Army is 'always looking at new ways to provide more performance to the aircraft, whether it's making components lighter, whether it's adding more power, whether it's adding additional fuel consumption capabilities,' Phillips said, 'We always look at that and I think we'll continue to look at that regardless of the outcome.'
Yahoo
05-05-2025
- Yahoo
US Army soldier found dead in Honduras
An Army helicopter pilot was found dead on Saturday, May 3 in Honduras, U.S. Southern Command's Joint Task Force-Bravo announced Sunday evening. The U.S. military said that 1st Lt. Marciano Parisano, 25, of Cibolo, Texas, was found dead in Comayagua, Honduras on May 3, 2025. According to local Honduran media, he was found near the Chiquito River area. Police searched the area for several hours and recovered a damaged phone which they believe was Parisano's. He was serving as a UH-60 helicopter pilot with 1st Battalion, 228 Aviation Regiment. Joint Task Force-Bravo said that Parisano was on a liberty pass when he went off base. An investigation is ongoing. 'It is with profound sadness and heavy hearts; we acknowledge the passing of Lieutenant Marciano Parisano. He served our unit and mission here at Soto Cano Air Base with dignity, pride and courage,' Army Col. Daniel Alder, head of Joint Task Force-Bravo, said in a statement Sunday night. As part of his duties, Parisano was assigned to Soto Cano Air Base — the main post for Joint Task Force-Bravo, the U.S. military's lead expeditionary force in central and southern America — is located. 'As a UH-60 Blackhawk pilot with the 228 Aviation Regiment, his contribution to our team is immeasurable. He will be deeply missed by all who had the privilege to know him and serve with him,' Alder's statement continued. 'The command team extends our deepest condolences to 1st Lt. Marciano Parisano's family, friends and loved ones. We stand with you in this time of grief. One soldier lost is one too many.' Commandant says Marines should have a say in whether they change duty stations Space Force Special Operations Command is on its way Army reverses course on banning fun and games for soldiers in Kuwait A meal card foul-up at Fort Johnson underscores a bigger Army problem Sailor wins $7,500 settlement after his car was towed and auctioned off while deployed
Yahoo
11-04-2025
- General
- Yahoo
Helicopter Crash Pilot Sean Johnson Posted Eerie Video Before Death
The pilot who died with a family of five in a helicopter crash in New York City's Hudson River was a NAVY Seal named Sean Johnson. On March 27, Johnson posted a video to his Facebook page that shows him piloting a helicopter over lower Manhattan. "When it all comes together," he captioned the Facebook reel, including the captions #tours #charter and #nyc. In the comment thread, he identified the craft as a "Bell 206L4." Johnson's Facebook profile picture shows him piloting a helicopter, and his cover photo is a picture of Manhattan. Gothamist identified Johnson as the pilot of the Bell 206 tourist helicopter which crashed and ended up submerged in the Hudson River in New York City on April 10, 2025. The pilot "radioed about needing to refuel minutes before the helicopter crashed into the chilly waters," Fox News reported, citing the CEO of the company that owned the helicopter, Michael Roth. Siemens executive Agustin Escobar, his wife, Mercè Camprubí Montal, and their three kids died in the crash, as did the pilot, The Associated Press reported. On March 6, Johnson posted another photo with a helicopter and wrote, "Windy City boy, in the Big Apple." According to his Facebook page, he was a helicopter pilot, "veteran, outdoors lover, and lifter of heavy metal." Johnson's recent Facebook pages included a post about the death of actor Val Kilmer. "Iceman forever," he wrote. Friends filled up the comment thread under his helicopter video with tributes. "I was telling my buddy about how you became a pilot. Just a couple of weeks back. Rest in peace," one wrote. "Thank you for sharing your journey with us. Fair winds shipmate," another person wrote. His page identified him as a "struggling co-pilot at Billings Flying Service," and a former UH-60 co-pilot at Heli-1 Corporation" who studied as a commercial pilot at Southern Utah University and Central Texas College, as well as at Embry-Riddle Aeronautical University. Johnson's page says he was from Chicago, Illinois. According to Gothamist, Johnson, 36, was a Navy SEAL veteran who had recently moved to New York. 'I'm just at loss for words. I don't even know what happened,' Johnson's wife Kathryn Johnson told Gothamist."It's just hard right now.' She told the site that Johnson worked in the past as a celebrity bodyguard and for a television show. Remi Adeleke shared a photo of Johnson in an aircraft to Instagram and wrote, "This is devastating. I just spoke with Sean's wife. The news publicized the name of the Siemens Exec and his family, but not the pilot. @its_me_kat3 asked me to share who Sean Johnson was so his name doesn't get lost or forgotten," the post says. "I met Sean when he was a new tech in the SEAL Teams. I was an E-6 at the time, and Sean stood out immediately—vibrant, humble, respectful, and hungry to learn. Every time I stepped into his workspace, we'd chop it up about life, the Teams, and his future. He'd always tell me he wanted to be a pilot someday. I'd remind him, 'Stay locked in. Do the work—and you'll get there.' And he did," the post continued.
Forbes
09-04-2025
- Health
- Forbes
A Non-Opioid Pain Medicine Exists. Will The FDA Act?
Military doctors and other soldiers carry a wounded soldier to a UH-60 medivac helicopter some 60kms ... More northeast of Baghdad 06 May 2003. The military made dramatic advances in battlefield pain management during the wars in Afghanistan and Iraq (Photo by ROBERTO SCHMIDT/AFP via Getty Images) Morphine has been the mainstay for treating pain since the Civil War. Although doctors recognized long ago that prolonged use of morphine can lead to addiction, nothing changed for 150 years. That's because there were no practical alternatives. The good news is that an effective non-opioid pain medicine exists. The bad news is that the FDA has not yet approved the medication's use for this purpose. Opioid abuse is ravaging families and communities across the United States. More than 81,000 opioid overdose deaths occurred in 2022, six times the number recorded in 1999. President Trump first declared the opioid crisis a public health emergency in 2017. His declaration was officially renewed in 2024. Although overdose deaths have declined somewhat in the past two years, they remain the leading cause of death among Americans aged 18-44. More must be done. Ketamine, an anesthetic, was first approved by the FDA 50 years ago. Its low cost and wide safety margin quickly made it a popular choice for surgery worldwide. The WHO classified it as an essential medicine in 1985. Recently, ketamine has also shown promise in treatment-resistant depression. Unfortunately, media coverage of that development, along with the rapid proliferation of 'ketamine clinics,' online prescribing and a celebrity death overshadowed another, equally promising use for ketamine: as an non-opioid alternative to treat acute pain. Ketamine's pain-relieving properties at doses far below those required for anesthesia have been recognized for years. And unlike morphine, ketamine tends to preserve blood pressure and breathing, even when administered to unstable patients. When the U.S. military entered Afghanistan in 2001 and Iraq in 2003, morphine was its primary drug for treating pain on the battlefield. It was soon supplemented by even more potent opioids, including fentanyl lozenges and hydromorphone. Near the end of the decade, growing concern about the opioids led military doctors to consider ketamine as an alternative. When used to treat wounded soldiers, ketamine provides excellent pain relief. Some who receive it report little or no recall of their acute event. Based on this success, the military developed guidelines for ketamine's use, trained its medics and corpsmen to administer it and supplied the medication to units deploying for combat. When word got out of the military's favorable experience, several civilian EMS services and hospital ERs started using ketamine 'off-label' to treat pain. Prescribing FDA-approved medications for non-FDA-approved purposes is more common than many people realize. Nearly 40% of U.S. prescriptions are written 'off-label,' according to the Congressional Research Service. A man is loaded into an ambulance after he was injured by one of two bombs exploded during the 117th ... More Boston Marathon on April 15, 2013. (Photo by) Over the next several years, numerous clinical trials in civilian ERs and EMS services confirmed that low-dose ketamine works faster than morphine and is as safe and effective. Based on this evidence, five emergency care organizations, ten specialty societies endorsed its use to treat severe pain in emergency care settings. So did the military's Committee on Tactical Combat Casualty Care. Allowing medics and other emergency care professionals to administer small, fixed doses under medical supervision is safe. Using ketamine as a 'party drug' or to self-treat depression at home is not. On top of that, two heavily publicized deaths put ketamine in a bad light. Both involved highly unusual circumstances and much larger doses of ketamine than those used to treat pain. In 2019, Elijah McClain, a young, unarmed Black man, was violently tackled by three police officers, twice put in chokeholds, and pinned to the ground. When paramedics arrived shortly thereafter, they administered a large dose of ketamine for presumed 'agitated delirium.' Shortly thereafter, Mr. McClain went into cardiac arrest. The contract medical examiner retained for the case concluded that McClain's death was 'most likely the result of ketamine toxicity.' Four years later, a Colorado jury found both paramedics guilty of negligent homicide. In 2023, Hollywood actor Matthew Perry consumed a large quantity of ketamine and then climbed into his hot tub. Because no one was with him at the time, he drowned. Two months later, the L.A. County coroner ruled that Perry's death was caused by "acute effects of ketamine.' Drowning, along with coronary artery disease and concurrent use of an opioid, buprenorphine, were listed as 'contributing factors.' In contrast to the annual toll of opioid-related deaths, deaths due to ketamine are rare. CDC recently analyzed four years of data on fatal drug overdoses reported by 44 states and the District of Columbia. A total of 228,668 deaths were identified. Ketamine was detected among other drugs in 912 (0.4%) of these fatalities, listed as 'involved' in 440 (0.2%), and was the only substance involved in 24 (0.01%) deaths—an average of six per year. To put this number in perspective, overdoses with acetamenophen account for about 500 deaths per year in the U.S. Because the FDA has only approved ketamine as an anesthetic, manufacturers produce it in multidose vials of three different strengths. In high-stress emergencies, calculating the correct dose to withdraw from a vial takes time and increases the risk of error. This is why, for more than a decade, the U.S. military has sought FDA approval of ketamine to treat severe pain in combat and other time-urgent emergency care settings. If (or more likely, when) the FDA finally grants approval, military and civilian teams should be able to acquire prepackaged doses of ketamine or better yet, preloaded automatic injectors that will enable them to relieve the pain experienced by seriously injured patients more quickly and safely. Additionally, pre-loaded injectors are more difficult to divert than multi-dose vials. Food And Drug Administration headquarters in White Oak, Maryland. (Photo by Sarah Silbiger/Getty ... More Images) Rather than accept the large body of real-world evidence of the safety and efficacy of low-dose ketamine as an analgesic, the FDA wants additional studies done to pinpoint the best dose and to prove to its satisfaction that this battle-tested drug is effective at reducing or relieving pain. This will take time and money. If the FDA does not reconsider its position, I hope that the U.S. military quickly sponsors the needed research so its medics, corpsmen and doctors, as well as civilian EMS and ER staff, can reduce their longstanding reliance on morphine, fentanyl, and other opioid analgesics to treat severe pain.
